U.S. markets open in 5 hours 44 minutes

Y-mAbs Therapeutics, Inc. (YMAB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
32.57+1.20 (+3.83%)
At close: 4:00PM EDT
Sign in to post a message.
  • D
    Diane
    This Week's Top Gainers in U.S. Stocks 🇺🇸

    https://stockreport.tips/Top-Market-Gainers
    Bullish
  • H
    Herman
    Y-mAbs - Q1'21 results indicate good start of Danyelza launch
    YMAB US - Close: $28.65 - BUY, PT: $60.00
    Y-mAbs reported Q1'21 results with $5.4m in revenue composed of the first Danyelza sales, and $62.0m in additional income from the PRV sale associated with Danyelza approval. R&D expenses increased to $21.6m (Q1'20: $18.6m) and SG&A expenses increased to $12.0m (Q1'20: $8.1m). Net income was $33.4m (Q1'21: -$26.2m). Given that the first Danyelza orders came in February, we believe that sales are on track to our FY'21 estimate of $30.1m. On the pipeline side, the company expects to i) resubmit the omburtamab BLA for CNS/LM in Q2/Q3'21, ii) data update for Danyelza from investigator-initiated phase II study in frontline HR-NB at ASCO in Jun'21, iii) start of a pivotal phase II studies for Danyelza in frontline HR-NB and DIPG in 2021, and iv) first IND filing for SADA construct in Q4'21.
  • H
    Herman
    YMAB will be $60 soon!

    Kempen: Y-mAbs - Q1'21 results indicate good start of Danyelza launch
    YMAB US - Close: $34.20 - BUY, PT: $60.00
    Bullish
  • Y
    Yahoo Finance Insights
    Y-mAbs Therapeutics is down 7.00% to 27.90
  • J
    John Wick Janitor
    $ASTC conversation
    Got alerted with this.
    32% discount from yesterday’s close?

    You know you won’t get a lemon from the janitor but all $

    Last year and this year’s winner calls:
    $nio $tsla $otlk $itrm $vyne $ymab $crvs $cnsp $ocgn $nndm $cciv $bngo
    I DONT REMEMBER THE REST!
    Pardon the 65 year old janitor mates

    Don’t be late (again!). Accumulate. FOMOs welcome

    *This is for entertainment purposes only. Do your own dd. Do not copy me
    Bullish
  • Y
    Yahoo Finance Insights
    Y-mAbs Therapeutics is down 6.74% to 26.57
  • Y
    Yahoo Finance Insights
    Y-mAbs Therapeutics is up 7.81% to 33.82
  • C
    CREED
    Any thoughts on revenue for todays FDA approval?
    Bullish
  • H
    Hari Seek
    Fraud report.
    Bearish
  • C
    CREED
    Wondering why the chatter on this stock is so quiet given the rich and deep pipeline. A couple of approvals last year, collaborations and a ton of phase 2 trials and more, this has 3X plus written all over it and a buyout in their future. Thoughts?
    Bullish
  • J
    Jack Cassidy
    I can not understand why the short positions are flat. The last 10 Q was not positive. YMAB has not seen revenue since 2016. S,G&A is up from $6.9 million to $11.6 million. In the last quarter they cut R&D by $9 million. Is cutting R&D a good prescription for a biotech company. Outstanding shares are up about 2 million in the last year. What does that mean to current shareholders when and if a turnaround occurs? Retained earnings (Accumulated deficit) is up $100 million in the last four quarters.
  • Y
    Yahoo Finance Insights
    Y-mAbs Therapeutics is up 5.47% to 26.98
  • Y
    Yahoo Finance Insights
    Y-mAbs Therapeutics is up 6.56% to 30.53
  • Q
    Que
    I missed the open sooooo I will wait for the lock out to expire. Everything was in place just my timing was off. GL all.
  • D
    DrThrill
    too bad. It was opened too high. No profit room left for common stock players.
  • Y
    Yahoo Finance Insights
    Y-mAbs Therapeutics is up 5.48% to 27.83
  • J
    Jack Cassidy
    YMAB is not looking good from a numbers standpoint
    No inventory, no trade accounts receivable
    Additional Paid-in Capital balance for last four quarters
    $228.5M, $364.7M, $367.2, $378.4
    That means new investors have put in $149.9 million into the company over the last year
    Accumulated deficit balance has grown over the last four quarters
    ($142.7M), ($165.8M), ($192.0M), (232.4M)
    That means the total lost since inception has grown by $99.7 million in the last year

    I am short.
  • Y
    Yahoo Finance Insights
    Y-mAbs Therapeutics is up 7.50% to 40.99
  • P
    Paren
    Hi everyone
  • C
    CREED
    anyone listening on on the 12pm ET call?
    Bullish